Analystreport

Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $80.00 price target on the stock.

Prestige Consumer Healthcare Inc.  (PBH) 
Last prestige consumer healthcare inc. earnings: 2/6 06:00 am Check Earnings Report
US:NYSE Investor Relations: ir.prestigebrands.com